Journal
NUTRIENTS
Volume 13, Issue 2, Pages -Publisher
MDPI
DOI: 10.3390/nu13020320
Keywords
magnesium; magnesium deficiency; magnesium supplementation; obesity; metabolic syndrome; type 2 diabetes; gut microbiota; vitamin D
Categories
Funding
- University of Milan
Ask authors/readers for more resources
Magnesium (Mg2+) deficiency is often underestimated in Western countries, especially in obese individuals with type 2 diabetes and metabolic syndrome. Proper intake of Mg2+ can help improve metabolic syndrome by regulating gene expression, proteomic profile, and impacting intestinal microbiota and vitamin metabolism.
Magnesium (Mg2+) deficiency is probably the most underestimated electrolyte imbalance in Western countries. It is frequent in obese patients, subjects with type-2 diabetes and metabolic syndrome, both in adulthood and in childhood. This narrative review aims to offer insights into the pathophysiological mechanisms linking Mg2+ deficiency with obesity and the risk of developing metabolic syndrome and type 2 diabetes. Literature highlights critical issues about the treatment of Mg2+ deficiency, such as the lack of a clear definition of Mg2+ nutritional status, the use of different Mg2+ salts and dosage and the different duration of the Mg2+ supplementation. Despite the lack of agreement, an appropriate dietary pattern, including the right intake of Mg2+, improves metabolic syndrome by reducing blood pressure, hyperglycemia, and hypertriglyceridemia. This occurs through the modulation of gene expression and proteomic profile as well as through a positive influence on the composition of the intestinal microbiota and the metabolism of vitamins B1 and D.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available